Other uses include non-invasive imaging of claudin-4-overexpressing pancreatic cancers using radiolabeled or fluorescently labeled cCpE in conjunction with single-photon emission computerized tomography scanning or fluorescence reflectance imaging and fluorescence-mediated tomography [103,104]. Here, CLDN4 is linked to pancreatic neoplasm.